Torasemide in chronic heart failure: results of the TORIC study, European Journal of Heart Failure, vol.35, issue.4, pp.507-513, 2002. ,
DOI : 10.1016/S0008-6363(97)00091-6
Torasemide Inhibits Angiotensin II??Induced Vasoconstriction and Intracellular Calcium Increase in the Aorta of Spontaneously Hypertensive Rats, Hypertension, vol.34, issue.1, pp.138-143, 1999. ,
DOI : 10.1161/01.HYP.34.1.138
Effects of loop diuretics on angiotensin II-stimulated vascular smooth muscle cell growth, Nephrology Dialysis Transplantation, vol.16, issue.suppl 1, pp.14-17, 2001. ,
DOI : 10.1093/ndt/16.suppl_1.14
A novel loop diuretic, torasemide, inhibits thromboxane A2-induced contraction in the isolated canine coronary artery, Prostaglandins, Leukotrienes and Essential Fatty Acids, vol.45, issue.2, pp.121-124, 1992. ,
DOI : 10.1016/0952-3278(92)90227-A
Anti-aldosteronergic effect of torasemide, European Journal of Pharmacology, vol.205, issue.2, pp.145-150, 1991. ,
DOI : 10.1016/0014-2999(91)90812-5
Multiple aspects of mineralocorticoid selectivity, Am J Physiol Renal Physiol, vol.280, pp.181-192, 2001. ,
Aldosterone, mineralocorticoid receptor, and heart failure, Molecular and Cellular Endocrinology, vol.350, issue.2, pp.266-272, 2012. ,
DOI : 10.1016/j.mce.2011.06.038
The Effect of Spironolactone on Morbidity and Mortality in Patients with Severe Heart Failure, New England Journal of Medicine, vol.341, issue.10, pp.709-717, 1999. ,
DOI : 10.1056/NEJM199909023411001
Eplerenone, a Selective Aldosterone Blocker, in Patients with Left Ventricular Dysfunction after Myocardial Infarction, New England Journal of Medicine, vol.348, issue.14, pp.1309-1321, 2003. ,
DOI : 10.1056/NEJMoa030207
Eplerenone in Patients with Systolic Heart Failure and Mild Symptoms, New England Journal of Medicine, vol.364, issue.1, pp.11-21, 2011. ,
DOI : 10.1056/NEJMoa1009492
Impact of Treatment on Myocardial Lysyl Oxidase Expression and Collagen Cross-Linking in Patients With Heart Failure, Hypertension, vol.53, issue.2, pp.236-242, 2009. ,
DOI : 10.1161/HYPERTENSIONAHA.108.125278
Identification of a Potential Cardiac Antifibrotic Mechanism of Torasemide in Patients With Chronic Heart Failure, Journal of the American College of Cardiology, vol.50, issue.9, pp.859-867, 2007. ,
DOI : 10.1016/j.jacc.2007.04.080
Effects of loop diuretics on myocardial fibrosis and collagen type I turnover in chronic heart failure, Journal of the American College of Cardiology, vol.43, issue.11, pp.2028-2035, 2004. ,
DOI : 10.1016/j.jacc.2003.12.052
Heterodimerization of Mineralocorticoid and Glucocorticoid Receptors at a Novel Negative Response Element of the 5-HT1A Receptor Gene, Journal of Biological Chemistry, vol.6, issue.17, pp.14299-14307, 2001. ,
DOI : 10.1073/pnas.96.26.14724
Identification of Permissive Insertion Sites for Generating Functional Fluorescent Mineralocorticoid Receptors, Endocrinology, vol.153, issue.7, pp.3517-3525, 2012. ,
DOI : 10.1210/en.2012-1210
Early Aldosterone-Regulated Genes in Cardiomyocytes: Clues to Cardiac Remodeling?, Endocrinology, vol.148, issue.4, pp.1502-1510, 2007. ,
DOI : 10.1210/en.2006-1438
Cooperation between structural elements in hormonoregulated transcription from the mouse mammary tumor virus promoter, Nucleic Acids Research, vol.19, issue.7, pp.1563-1569, 1991. ,
DOI : 10.1093/nar/19.7.1563
Conditional gene expression in renal collecting duct epithelial cells: use of the inducible Cre-lox system, AJP: Renal Physiology, vol.286, issue.1, pp.180-187, 2004. ,
DOI : 10.1152/ajprenal.00301.2002
A new mathematical model for relative quantification in real-time RT-PCR, Nucleic Acids Research, vol.29, issue.9, p.45, 2001. ,
DOI : 10.1093/nar/29.9.e45
Subcellular localization of mineralocorticoid receptors in living cells: Effects of receptor agonists and antagonists, Proceedings of the National Academy of Sciences, vol.109, issue.4, pp.2973-2978, 1998. ,
DOI : 10.1210/mend-5-2-217
Molecular Signature of Mineralocorticoid Receptor Signaling in Cardiomyocytes: From Cultured Cells to Mouse Heart, Endocrinology, vol.151, issue.9, pp.4467-4476, 2010. ,
DOI : 10.1210/en.2010-0237
Update on Aldosterone Antagonists Use in Heart Failure With Reduced Left Ventricular Ejection Fraction Heart Failure Society of America Guidelines Committee, Journal of Cardiac Failure, vol.18, issue.4, pp.265-281, 2012. ,
DOI : 10.1016/j.cardfail.2012.02.005
The 2012 ESC Guidelines on Heart Failure, Eur Heart J, vol.33, pp.1703-1704, 2012. ,
Multi-Tasking RGS Proteins in the Heart: The Next Therapeutic Target?, Circulation Research, vol.96, issue.4, pp.401-411, 2005. ,
DOI : 10.1161/01.RES.0000158287.49872.4e
Pleiotropic functions of plasminogen activator inhibitor-1, Journal of Thrombosis and Haemostasis, vol.268, issue.1, 2005. ,
DOI : 10.1172/JCI200318038
Conformational Pathology of the Serpins: Themes, Variations, and Therapeutic Strategies, Annual Review of Biochemistry, vol.78, issue.1, pp.147-176, 2009. ,
DOI : 10.1146/annurev.biochem.78.082107.133320
Matricellular proteins in the heart: possible role during stress and remodeling, Cardiovascular Research, vol.64, issue.1, pp.24-31, 2004. ,
DOI : 10.1016/j.cardiores.2004.06.006
Tenascin-X deficiency mimics Ehlers-Danlos syndrome in mice through alteration of collagen deposition, Nature Genetics, vol.30, issue.4, pp.421-425, 2002. ,
DOI : 10.1038/ng850
Glycoforms of serum ?1-acid glycoprotein as markers of inflammation and cancer, Glycoconjugate Journal, vol.105, issue.3, pp.241-247, 1995. ,
DOI : 10.1007/BF00731326
Inflammation-sensitive plasma proteins are associated with increased incidence of heart failure: A population-based cohort study, Atherosclerosis, vol.202, issue.2, pp.617-622, 2009. ,
DOI : 10.1016/j.atherosclerosis.2008.05.038
Spironolactone, an aldosterone antagonist, acts as an antiglucocorticosteroid on the mouse mammary tumor virus promoter., Endocrinology, vol.130, issue.1, pp.430-436 ,
DOI : 10.1210/endo.130.1.1309341
Determinants of spironolactone binding specificity in the mineralocorticoid receptor, Journal of Molecular Endocrinology, vol.31, issue.3, pp.573-582, 2003. ,
DOI : 10.1677/jme.0.0310573
Glucocorticoids Activate Cardiac Mineralocorticoid Receptors During Experimental Myocardial Infarction, Hypertension, vol.54, issue.6, pp.1306-1312, 2009. ,
DOI : 10.1161/HYPERTENSIONAHA.109.136242
Mineralocorticoid Receptors in Myocardial Infarction, Hypertension, vol.54, issue.6, pp.1211-1212, 2009. ,
DOI : 10.1161/HYPERTENSIONAHA.109.140384
Cell-specific, promoter-dependent mineralocorticoid agonist activity of spironolactone, Mol Pharmacol, vol.51, pp.285-292, 1997. ,
Torsemide inhibits aldosterone secretion in vitro, Life Sciences, vol.63, issue.3, pp.45-50, 1998. ,
DOI : 10.1016/S0024-3205(98)00265-3
Torasemide inhibits transcardiac extraction of aldosterone in patients with congestive heart failure, Journal of the American College of Cardiology, vol.44, issue.11, pp.2252-2253, 2004. ,
DOI : 10.1016/j.jacc.2004.09.009
Aldosterone synthase (CYP11B2) expression and myocardial fibrosis in the failing human heart, Clinical Science, vol.102, issue.4, pp.381-386, 2002. ,
DOI : 10.1042/cs1020381
Effects of oral administration of furosemide and torsemide in healthy dogs, American Journal of Veterinary Research, vol.68, issue.10, pp.1058-1063, 2007. ,
DOI : 10.2460/ajvr.68.10.1058
Effects of Torasemide on Left Ventricular Function and Neurohumoral Factors in Patients With Chronic Heart Failure, Circulation Journal, vol.67, issue.5, pp.384-390, 2003. ,
DOI : 10.1253/circj.67.384
The Effects of the Loop Diuretics Furosemide and Torasemide on Diuresis in Dogs and Cats, Journal of Veterinary Medical Science, vol.65, issue.10, pp.1057-1061, 2003. ,
DOI : 10.1292/jvms.65.1057
Use of the loop diuretic torsemide in three dogs with advanced heart failure, Journal of Veterinary Cardiology, vol.13, issue.4, pp.287-292, 2011. ,
DOI : 10.1016/j.jvc.2011.10.001